Nanobiotix (NBTX) Financials

$44.50

$2.99 (7.20%)

As on 26-Aug-2026 16:01EDT

Market cap

$2,213 Mln

Revenue (TTM)

$-- Mln

P/E Ratio

--

P/B Ratio

65

Div. Yield

0 %

Annual
Quarterly

Income Statement (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	29.64	-7.19	36.21	4.78	2.65	2.33
Cost of Revenue	--	--	--	0.99	--	--
Gross Profit	29.64	-7.19	36.21	4.78	2.65	2.33
Operating Expenses	40.46	61.20	62.99	51.48	55.23	38.75
Operating Profit (EBIT)	-10.82	-68.39	-26.78	-46.70	-52.58	-36.43
Other Income	--	--	--	--	--	--
Profit before Tax	-23.96	-68.03	-39.58	-57.03	-47.00	-33.58
Provision for Tax	0.00	0.10	0.12	0.01	0.01	0.01
Profit after Tax (Net Income)	-23.96	-68.13	-39.70	-57.04	-47.00	-33.59
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-57.04	-47.06	-33.59

Liabilities (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	-84.48	-65.70	-1.84	-27.05	26.79	70.47
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	94.74	74.19	45.87	48.88	38.13	44.52
Current Liabilities	57.51	58.94	49.87	37.94	36.85	19.04
Total Liabilities	67.76	67.42	93.90	59.77	101.77	134.03

Assets (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	5.01	5.95	6.56	7.41	8.71	8.78
Current Assets	62.75	61.47	87.34	52.36	93.06	125.25
Total Assets	67.76	67.42	93.90	59.77	101.77	134.03
Total Debt*	95.32	50.90	50.57	53.17	46.02	48.98
Net Current Assets	5.24	2.53	37.47	14.42	56.22	106.21

Cashflow (€ Mln)	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	-33.42	-19.55	-12.48	-37.10	-29.87	-27.54
Cash Flow from Investing Activities	-0.58	-0.96	-0.35	0.14	-0.24	-0.11
Cash from Financing Activities	37.42	-5.14	46.77	-5.65	-5.18	111.77
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS (€)	-0.50	-1.45	-1.02	-1.64	-1.35	-0.98
Cash EPS (€)	-0.47	-1.41	-0.98	-1.59	-1.31	-0.92
Adjusted Book Value (€)	--	--	--	--	0.77	2.05
Dividend per Share (€)	--	--	--	--	--	--
Cash Flow per Share (€)	-0.70	-0.41	-0.32	-1.06	-0.86	-0.80
Free Cash Flow per Share (€)	-0.71	-0.43	-0.33	-1.07	-0.86	-0.80

Profitability Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	1,208.63	-401.72	-106.09	-115.31	-48.90	-41.45
ROE (%)	31.91	201.73	274.85	44,738.04	-96.66	-97.99
ROA (%)	-35.45	-84.47	-51.67	-70.62	-39.87	-35.31
EBIT Margin (%)	-45.75	949.35	-66.94	-957.22	-1,781.83	-1,574.88
Net Margin (%)	-80.83	947.59	-109.64	-1,194.33	-1,775.71	-1,444.73
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	5.12	-1.20	6.58	0.80	0.14	-0.09
EBIT Growth (%)	80.13	-181.63	46.98	3.07	-28.81	21.73
Net Profit Growth (%)	64.83	-71.62	30.40	-21.36	-39.93	34.03
EPS Growth (%)	0.65	-0.41	0.38	-0.21	-0.38	0.57
Book Value Growth (%)	--	--	--	--	--	--

Solvency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	-1.13	-0.77	-27.42	-1.97	1.72	0.70
Short term debt to equity ratio	-0.05	-0.07	-2.72	-0.17	0.31	0.07
Current Ratio	1.09	1.04	1.75	1.38	2.53	6.58
Quick Ratio	--	--	1.75	1.30	2.61	8.70
Interest Coverage	-1.30	-8.44	-3.04	-7.83	-67.43	-109.96

Operating Efficiency Ratios	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	25.91	-118.71	8.19	59.51	147.13	166.67
Asset Turnover	0.44	-0.09	0.47	0.06	0.02	0.02
Receivable days	99.90	-292.15	29.30	257.59	536.05	403.04
Inventory Days	--	--	--	-11.50	--	--
Payable days	--	--	--	1,667.73	--	--
Cash Conversion Cycle	--	--	--	-1,421.63	--	--